ЕВРОПЕЙСКОЕ ИССЛЕДОВАНИЕ ПРОФИЛАКТИКИ СЕРДЕЧНО-СОСУДИСТЫХ  ЗАБОЛЕВАНИЙ И САХАРНОГО ДИАБЕТА – EUROASPIRE V (EUROPEAN ACTION  ON SECONDARY AND PRIMERY PREVENTION BY INTERVANTION TO REDUCE EVENTS) В КЫРГЫЗСКОЙ РЕСПУБЛИКЕ: ОБОСНОВАНИЕ И ДИЗАЙН ИССЛЕДОВАНИЯ

S.S. Abilova; M.S. Tursunbaev; K.K. Baigazieva; U.M. Toktomamatov; U.A. Zakirov; A.A. Asanbaev; G.M. Baitova; E.M. Mirrakhimov

doi:10.54890/.v2i2.282

S.S. Abilova M.S. Tursunbaev K.K. Baigazieva U.M. Toktomamatov U.A. Zakirov A.A. Asanbaev G.M. Baitova E.M. Mirrakhimov

DOI:

https://doi.org/10.54890/.v2i2.282

Abstract

Summary. The aim of the study is to identify risk factors in patients with CVD and people with high risk of CVD. There will be described the management such risks through lifestyle changes and use of medicine, with an objective assessment of the clinical implementation of scientific approaches reflected in the current European Recommendations. Material and methods: 400 coronary patients will be surveyed at the hospital stage and 200 patients with high CVD risk at the outpatient stage from 18 to 80 years. The result of the study will provide an opportunity to analyze the current situation in the prevention of CVD in the Kyrgyz Republic.

Keywords:

cardiovascular diseases, prevention, risk factors.

References

1. The global economic burden of non-communicable diseases, Geneva: World Economic Forum (2011) D.E. Bloom, E.T. Cafiero, E. Jané-Llopis et al. // Режим доступа: http://apps.who.int/medicinedocs/ en/d/Js18806en/

2. Профилактика неинфекционных заболеваний и борьба с ними в Кыргызстане: Аргументы в пользу инвестирования Режим доступа:http:// www.euro.who.int/ __data /assets/pdf_file/0007/349684/BizzCase-KGZ-Ru-web.pdf

3. Joint Mission of the United Nations Interagency Task Force on the Prevention and Control of Noncommunicable Diseases: Kyrgyzstan, 14–17 March 2016. Geneva: World Health Organization – Электронный ресурс / Режим доступа: http://www. who.int/ncds/un-task-force/en/

4. EUROASPIRE Study Group. Clinical reality of coro-nary prevention guidelines: a comparison of EU-ROASPIRE I and II in nine countries [Текст] // Lan-cet. – 2001. – V. 357. – С. 995-1001.

5. Kotseva, K. EUROASPIRE III: A survey on the life-style, risk factors and use of cardioprotective drug therapies in coronary patients from twenty two Euro-pean countries. EUROASPIRE Study Group / K. Kotseva, D. Wood, De Backer G. //Europ J Cardio-vasc Prev Rehabilitation. - 2009. - №16. - P. 121-37.

6. EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factors and therapeutic management of coronary patients from twenty four European countries // K. Kotseva, D. Wood, De Backer G. et al. // Eur J Prev Cardiology. - 2015 as 10. 1177/2047487315569401.